tradingkey.logo

STAAR Surgical Co

STAA

18.990USD

+1.230+6.93%
Horário de mercado ETCotações atrasadas em 15 min
940.44MValor de mercado
PerdaP/L TTM

STAAR Surgical Co

18.990

+1.230+6.93%
Mais detalhes de STAAR Surgical Co Empresa
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Informações da empresa
Código da empresaSTAA
Nome da EmpresaSTAAR Surgical Co
Data de listagemFeb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
Número de funcionários1157
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 24
Endereço1911 Walker Ave
CidadeMONROVIA
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal91016
Telefone16263037902
Sitehttps://www.staar.com/
Código da empresaSTAA
Data de listagemFeb 24, 1992
CEOMr. Stephen C. (Steve) Farrell, CPA
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
+54.07%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
-57.51%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
-14.65%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
4.60K
+27.61%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Independent Director
Independent Director
--
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
+54.07%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
-57.51%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
-14.65%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
4.60K
+27.61%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
Por RegiãoUSD
Nome
Receita
Proporção
Others
18.02M
42.30%
Japan
11.39M
26.75%
South Korea
7.33M
17.22%
U. S.
5.46M
12.82%
China
389.00K
0.91%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
ICLs
41.50M
97.44%
Other surgical products
1.09M
2.56%
Distribuição de ações
Atualizado em: dom, 15 de jun
Atualizado em: dom, 15 de jun
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Broadwood Capital, Inc.
27.35%
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
8.87%
Armistice Capital LLC
6.06%
Soleus Capital Management, L.P.
5.17%
Other
38.39%
Investidores
Investidores
Proporção
Broadwood Capital, Inc.
27.35%
BlackRock Institutional Trust Company, N.A.
14.16%
The Vanguard Group, Inc.
8.87%
Armistice Capital LLC
6.06%
Soleus Capital Management, L.P.
5.17%
Other
38.39%
Tipos de investidores
Investidores
Proporção
Hedge Fund
45.54%
Investment Advisor
39.69%
Investment Advisor/Hedge Fund
15.50%
Research Firm
4.34%
Pension Fund
1.05%
Sovereign Wealth Fund
0.92%
Individual Investor
0.51%
Bank and Trust
0.35%
Venture Capital
0.06%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
542
53.50M
108.02%
-4.10M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
2023Q1
670
50.91M
105.54%
-1.16M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Broadwood Capital, Inc.
13.55M
27.35%
+1.09M
+8.75%
Apr 22, 2025
BlackRock Institutional Trust Company, N.A.
7.01M
14.16%
-305.44K
-4.17%
Mar 31, 2025
The Vanguard Group, Inc.
5.41M
10.92%
-439.86K
-7.52%
Mar 31, 2025
Armistice Capital LLC
3.00M
6.06%
+2.13M
+244.04%
Mar 31, 2025
Soleus Capital Management, L.P.
2.56M
5.17%
+2.56M
--
Mar 31, 2025
Resona Asset Management Co., Ltd.
2.17M
4.38%
+669.43K
+44.62%
Mar 31, 2025
State Street Global Advisors (US)
1.99M
4.03%
-57.87K
-2.82%
Mar 31, 2025
Yunqi Capital Limited
1.94M
3.91%
+1.17M
+152.48%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.19M
2.4%
+14.77K
+1.26%
Mar 31, 2025
American Capital Management, Inc.
1.01M
2.04%
+161.75K
+19.06%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
SPDR S&P Health Care Equipment ETF
1.75%
ROBO Global Healthcare Technology & Innovation ETF
1.63%
Invesco S&P SmallCap Health Care ETF
0.59%
Royce Quant Small-Cap Quality Value ETF
0.2%
WisdomTree US SmallCap Quality Growth Fund
0.14%
Principal U.S. Small-Cap ETF
0.1%
SPDR S&P SmallCap 600 ESG ETF
0.09%
SPDR S&P 600 Small Cap Growth ETF
0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.07%
iShares ESG Select Screened S&P Small-Cap ETF
0.07%
Ver Mais
SPDR S&P Health Care Equipment ETF
Proporção1.75%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.63%
Invesco S&P SmallCap Health Care ETF
Proporção0.59%
Royce Quant Small-Cap Quality Value ETF
Proporção0.2%
WisdomTree US SmallCap Quality Growth Fund
Proporção0.14%
Principal U.S. Small-Cap ETF
Proporção0.1%
SPDR S&P SmallCap 600 ESG ETF
Proporção0.09%
SPDR S&P 600 Small Cap Growth ETF
Proporção0.07%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporção0.07%
iShares ESG Select Screened S&P Small-Cap ETF
Proporção0.07%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI